OPTION AGREEMENT UNDER THE CATALENT, INC. 2018 OMNIBUS INCENTIVE PLANOption Agreement • December 8th, 2023 • Catalent, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 8th, 2023 Company Industry JurisdictionPursuant to the Option Grant Notice (the “Grant Notice”) delivered to the Participant (as defined in the Grant Notice), and subject to the terms of this Option Agreement, including, as applicable, any special terms and conditions for the Participant’s country set forth in Appendix 1 attached hereto (collectively, this “Agreement”), and the Plan (as defined below), Catalent, Inc. (the “Company”) and the Participant agree as follows.
OPTION AGREEMENT FOR NON-U.S. PARTICIPANTS UNDER THE CATALENT, INC.Option Agreement • November 1st, 2022 • Catalent, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 1st, 2022 Company Industry JurisdictionPursuant to the Option Grant Notice for Non-U.S. Participants (the “Grant Notice”) delivered to the Participant (as defined in the Grant Notice), and subject to the terms of this Option Agreement for Non-U.S. Participants, including any special terms and conditions for the Participant’s country set forth in Appendix 1 attached hereto (collectively, this “Agreement”), and the Plan (as defined below), Catalent, Inc. (the “Company”) and the Participant agree as follows.
OPTION AGREEMENT FOR NON-U.S. PARTICIPANTS UNDER THE CATALENT, INC.Option Agreement • May 7th, 2019 • Catalent, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 7th, 2019 Company Industry JurisdictionPursuant to the Option Grant Notice for Non-U.S. Participants (the “Grant Notice”) delivered to the Participant (as defined in the Grant Notice), and subject to the terms of this Option Agreement for Non-U.S. Participants, including any special terms and conditions for the Participant’s country set forth in Appendix 1 attached hereto (collectively, this “Agreement”), and the Plan (as defined below), Catalent, Inc. (the “Company”) and the Participant agree as follows.